DESIGN THERAPEUTICS I
5.9700
27-十一月-24 15:45:00
15 分钟延时
股票
-0.1800
-2.93%
今日范围
5.8700 - 6.2500
ISIN
N/A
来源
NASDAQ
-
Design Therapeutics Highlights Upcoming Milestones and Reports Second Quarter 2022 Financial Results
08 8月 2022 15:05:01 条件 Nasdaq GlobeNewswire
-
Design Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference
03 8月 2022 05:30:00 条件 Nasdaq GlobeNewswire
-
Design Therapeutics to Present at the 2022 Jefferies Healthcare Conference
01 6月 2022 05:30:00 条件 Nasdaq GlobeNewswire
-
09 5月 2022 15:05:01 条件 Nasdaq GlobeNewswire
-
30 3月 2022 05:30:00 条件 Nasdaq GlobeNewswire
-
10 3月 2022 15:02:00 条件 Nasdaq GlobeNewswire
-
09 3月 2022 05:30:00 条件 Nasdaq GlobeNewswire
-
28 2月 2022 15:05:00 条件 Nasdaq GlobeNewswire
-
Design Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
10 2月 2022 05:30:00 条件 Nasdaq GlobeNewswire
-
Design Therapeutics Appoints Drug Development Expert, Jae Kim, M.D., as Chief Medical Officer
01 2月 2022 15:05:01 条件 Nasdaq GlobeNewswire
-
Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
09 11月 2021 15:05:01 条件 Nasdaq GlobeNewswire
-
08 9月 2021 05:30:00 条件 Nasdaq GlobeNewswire
-
Design Therapeutics Reports GeneTAC™ Portfolio Progress and Second Quarter 2021 Results
09 8月 2021 15:05:00 条件 Nasdaq GlobeNewswire
-
Design Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
07 6月 2021 15:10:00 条件 Nasdaq GlobeNewswire
-
Design Therapeutics Expands Board of Directors with Key Appointments
07 6月 2021 15:05:00 条件 Nasdaq GlobeNewswire
-
Design Therapeutics Announces Business Highlights and Reports First Quarter 2021 Financial Results
10 5月 2021 15:05:00 条件 Nasdaq GlobeNewswire